MGI Tech Announces Exclusive Licensing Agreement with Swiss Rockets AG to Globalize Proprietary CoolMPSä Sequencing Technology

(PRNewsfoto/MGI)

SHENZHEN, China, Oct. 28, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced entering into an exclusive licensing agreement through its US subsidiaries – MGI US LLC and Complete Genomics Inc. – with Swiss Rockets AG, a Switzerland-based biotech firm, for the research, development, manufacture, and commercialization of exclusive sequencing products based on MGI's CoolMPSä technology and non-exclusive accessory products outside the Asia-Pacific and Greater China regions (i.e., Chinese Mainland, Hong Kong, Macau, and Taiwan). The strategic partnership is set to fully unlock the patent value and productization capabilities of CoolMPS, complementing MGI's tried-and-true StandardMPSä technology and cementing the company's leadership in the field of genomic sequencing.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.